Covista (CVSA) Cost of Revenue (2009 - 2026)

Covista (CVSA) has reported Cost of Revenue for 18 consecutive years, with $210.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cost of Revenue rose 5.43% year-over-year to $210.7 million; the TTM figure through Mar 2026 stood at $815.8 million (up 8.05% YoY), while the FY2025 annual figure was $771.4 million, up 10.43% from the prior year.
• Cost of Revenue climbed to $210.7 million in Q1 2026 per CVSA's latest filing, from $205.4 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $210.7 million in Q1 2026 and bottomed at $159.3 million in Q4 2022.
• Historically, Cost of Revenue has averaged $180.2 million across 5 years, with a median of $175.3 million in 2024.
• On a YoY basis, Cost of Revenue climbed as much as 44.4% in 2022 and fell as far as 11.7% in 2022.
• Covista's Cost of Revenue stood at $159.3 million in 2022, then climbed by 8.01% to $172.1 million in 2023, then advanced by 8.47% to $186.6 million in 2024, then grew by 10.07% to $205.4 million in 2025, then advanced by 2.58% to $210.7 million in 2026.
• Business Quant data shows CVSA's Cost of Revenue at $210.7 million in Q1 2026, $205.4 million in Q4 2025, and $200.8 million in Q3 2025.